These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3408889

  • 1. Prolonged erections following intracorporeal injection of medications to overcome impotence.
    Watters GR, Keogh EJ, Carati CJ, Earle CM, Wisniewski ZS, Tulloch AG, Lord DJ.
    Br J Urol; 1988 Aug; 62(2):173-5. PubMed ID: 3408889
    [Abstract] [Full Text] [Related]

  • 2. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG, Gilbert P, Wetterhauer U, Bähren W, Thon W, Altwein JE.
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE, Ellis LR, Kramer-Levien D.
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Priapism induced by intracavernous injection].
    Morales Concepción JC.
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
    Bardin ED, Krieger JN.
    Int Urol Nephrol; 1990 Oct; 22(2):147-52. PubMed ID: 2354895
    [Abstract] [Full Text] [Related]

  • 14. Physiology of erection and pharmacological management of impotence.
    Lue TF, Tanagho EA.
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risks of self-injection therapy for impotence.
    Millard RJ, Stricker PD, Lynch WJ, Dean TE, Murnaghan GF, Breslin FH.
    Med J Aust; 1996 Jul 15; 165(2):117-8. PubMed ID: 8692055
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.
    Corriere JN, Fishman IJ, Benson GS, Carlton CE.
    J Urol; 1988 Sep 15; 140(3):615-7. PubMed ID: 3411687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.